Application 211726
- Type
- ANDA
- Sponsor
- ANNORA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DROXIDOPA | DROXIDOPA | CAPSULE;ORAL | 300MG | No | No |
| 002 | DROXIDOPA | DROXIDOPA | CAPSULE;ORAL | 100MG | No | No |
| 003 | DROXIDOPA | DROXIDOPA | CAPSULE;ORAL | 200MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 31722-010 | Droxidopa | Droxidopa | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-010 | Droxidopa | Droxidopa | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-014 | Droxidopa | Droxidopa | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-015 | Droxidopa | Droxidopa | Camber Pharmaceuticals, Inc. | ANDA | Current |